NASA NOW EQUIPPED WITH ECHOLIGHT DEVICES FOR BONE HEALTH MONITORING IN SPACEFLIGHT SIMULATIONS
HOUSTON, Oct. 21, 2024 /PRNewswire/ — Echolight, a global leader in bone densitometry, has announced that NASA is now utilizing its proprietary Radiofrequency Echographic Multi-Spectrometry (REMS) technology to monitor bone health changes in a human bedrest study and assess the effects of unloading on bone mass during space missions. This marks a significant milestone for NASA’s efforts to understand and combat bone density loss in space, a critical aspect of astronaut health.
Revolutionary Technology for Bone Health
Through a simple, non-invasive ultrasound scan of axial anatomical sites like the spine and femur, REMS technology measures bone density and microarchitecture without the need for the radiation used in traditional X-ray scans. This groundbreaking, radiation-free approach allows NASA to perform repeated scans to monitor astronauts’ bone health over time, without exposing them to harmful radiation. Additionally, REMS automatically excludes artifacts that are typically present in other densitometry procedures, providing highly reliable diagnostic assessments.
Sergio Casciaro, CEO and founder of Echolight, commented, “Echolight is thrilled by this milestone in the US adoption of REMS devices. The diagnostic system for personalized, patient-centered bone health assessment has garnered significant interest among the US medical community, who are focused on reducing fragility fractures. This technology represents the future of bone health monitoring.”
NASA’s Vision for Bone Health Monitoring in Space
NASA’s ongoing efforts to understand bone health in space are of paramount importance, especially as future missions to the Moon and Mars will span long periods of time. Prof. Aenor Sawyer, Director of the UCSF Skeletal Health Service and UC Space Health, shared, “Echolight technology offers several potential benefits for space missions, including portability—its unit is the size of a small suitcase, fast scan times of under 10 minutes, and the ability to scan frequently with no harmful radiation. Currently, NASA cannot assess bone loss in astronauts during spaceflight in real-time or make immediate adjustments to their countermeasures. REMS could provide critical, in-mission information for long-duration missions to the Moon and Mars.”
This real-time bone health monitoring will help scientists track changes in astronauts’ bone density throughout space missions and enable timely adjustments to countermeasures. The ability to monitor and adjust in real-time is crucial to maintaining astronaut health, preventing fragility fractures, and ensuring their well-being during extended missions.
Echolight’s Growing Impact in Bone Health Technology
Echolight, established in Italy and headquartered in Lecce, has made significant strides since opening offices in the United States in 2020. The company’s sales network has expanded to more than 40 distributors worldwide, with hundreds of customers adopting the innovative REMS technology for patient bone health assessments. With its emphasis on personalized medicine, Echolight continues to lead the way in medical innovation, contributing to the improvement of human well-being.
Echolight has been awarded various certifications, including UNI CEI EN ISO 13485: 2016, Quality Management System UNI EN ISO 9001: 2015, CE mark, FDA clearance, and other global certifications. These accolades recognize the company’s cutting-edge solutions as best practices in bone health.
The Future of Space Health Monitoring
As NASA continues to prepare for longer and more complex space missions, the ability to monitor astronauts’ bone health in real-time is becoming more crucial. With its innovative REMS technology, Echolight has positioned itself as a key partner in space health research, offering an efficient, reliable, and non-invasive method for monitoring bone density changes. The successful integration of REMS into NASA’s health monitoring system will provide invaluable data, ensuring that astronauts maintain optimal bone health during their missions, both on Earth and in space.
This collaboration between Echolight and NASA marks a significant step forward in the future of space health and offers promising applications for the broader medical community. With the potential to revolutionize how bone health is assessed, the REMS technology will contribute to both space exploration and human health for years to come.
About Echolight
Founded as a spin-off of the Italian National Research Council, Echolight is at the forefront of medical innovation. The company has introduced cutting-edge solutions to contribute to human well-being, and its products have been adopted globally by both medical professionals and researchers. With a focus on personalized medicine and advanced diagnostics, Echolight continues to lead in the field of bone health, offering solutions that make a lasting impact.
For more information about Echolight and its REMS technology, please visit Echolight’s Website.
